Interim Segment Information (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of reconciliations to corresponding totals in the accompanying consolidated financial statements

	Three Months
	Ended March 31,
(all dollar amounts in thousands)	2013			2012

Net sales external customers:
Tissue	$	78,035		$	81,686
Paper	109,945			134,496

	$	187,980		$	216,182

Operating profit (loss):
Tissue	$	3,784		$	9,177
Paper	(41,156		)	289
Corporate & eliminations	(7,393		)	(6,150		)

	$	(44,765	)	$	3,316

	March 31,		December 31,
	2013		2012

Segment assets:
Tissue	$	398,767	$	378,278
Paper	233,318		271,793
Corporate & unallocated*	65,814		50,644

	$	697,899	$	700,715

* Segment assets of Tissue and Paper do not include intersegment accounts receivable, cash, deferred tax assets, and certain other assets, which are not identifiable with segments.

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details